{"ticker": {"uuid": "40540cf3-c5e0-49e4-8c46-1bc0db72e9a1", "symbol": "MBX", "name": "MBX Biosciences, Inc. Common Stock", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "MBX Biosciences (NASDAQ:MBX) Rating Lowered to \"Sell\" at Wall Street Zen", "summary": "Wall Street Zen has downgraded MBX Biosciences (NASDAQ:MBX) from a \"hold\" to a \"sell\" rating, despite other analysts like Barclays, Truist Financial, and Citizens JMP recently increasing their price targets. The stock currently holds a \"Moderate Buy\" consensus rating with a $63.0", "url": "https://www.marketbeat.com/instant-alerts/mbx-biosciences-nasdaqmbx-rating-lowered-to-sell-at-wall-street-zen-2026-07-20/", "source_name": "MarketBeat", "published_at": "2026-07-20T05:11:59", "published_display": "20 Jul 2026 05:11", "sentiment": "negative", "sentiment_pct": 39, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MBX Biosciences (NASDAQ:MBX) Trading 5.1% Higher - What's Next?", "summary": "MBX Biosciences (NASDAQ:MBX) shares increased by 5.1% on Friday, trading as high as $60.11 and closing at $61.30, despite a significant drop in trading volume. Analysts maintain a generally positive outlook, with a consensus \"Moderate Buy\" rating and an average price target of $6", "url": "https://www.marketbeat.com/instant-alerts/mbx-biosciences-nasdaqmbx-trading-51-higher-whats-next-2026-07-17/", "source_name": "MarketBeat", "published_at": "2026-07-17T17:11:13", "published_display": "17 Jul 2026 17:11", "sentiment": "positive", "sentiment_pct": 67, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is MBX Biosciences (MBX) Fairly Valued As New Leadership Takes Charge?", "summary": "MBX Biosciences (MBX) has appointed Steve Hoerter as CEO and Chairman and John Smither as CFO, following a significant surge in its stock price. The article examines the company's valuation using the price-to-book ratio, noting it appears expensive compared to the broader pharmac", "url": "https://www.sahmcapital.com/news/content/is-mbx-biosciences-mbx-fairly-valued-as-new-leadership-takes-charge-2026-07-17", "source_name": "Sahm", "published_at": "2026-07-17T09:11:59", "published_display": "17 Jul 2026 09:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "MBX Biosciences Announces CEO Transition and Leadership Updates", "summary": "MBX Biosciences announced a leadership transition, with CEO Kent P. Hawryluk stepping down on July 13, 2026. Steven Hoerter has been named the new President, CEO, and principal executive officer, while John Smither is confirmed as CFO. The company's stock currently holds a \"Buy\" ", "url": "https://www.theglobeandmail.com/investing/markets/stocks/MBX/pressreleases/3284381/mbx-biosciences-announces-ceo-transition-and-leadership-updates/", "source_name": "The Globe and Mail", "published_at": "2026-07-15T09:09:43", "published_display": "15 Jul 2026 09:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "$MBX stock is down 9% today. Here's what we see in our data.", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOemc1WEs1T3MxeGlNclJLMnU5SXlzQlJmcmxheGQzQW54RlJBc1c5dnprOUU4cHRHLW1Fa2Z1VjQzejNkNjRlelpqZWxLMm5qZVVpMFVNdjJ0TmdFM296WWJJQXdESVRwZmIzRmU2VElQRXBDZGcwODVBbTdZaUZPV2tXV0F0M0xRWlVfSm5mWXF4X1NHR3lmOGotSXE5cmpJ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-14T14:52:00+00:00", "published_display": "14 Jul 2026 14:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MBX Biosciences (NASDAQ:MBX) Shares Gap Down - Should You Sell?", "summary": "MBX Biosciences (NASDAQ:MBX) experienced a gap down at market open, falling from $60.04 to $52.82 before trading at $55.83. Despite the dip, analysts generally maintain a \"Moderate Buy\" consensus with an average price target of $60.22, though one analyst still recommends selling.", "url": "https://www.marketbeat.com/instant-alerts/mbx-biosciences-nasdaqmbx-shares-gap-down-should-you-sell-2026-07-14/", "source_name": "MarketBeat", "published_at": "2026-07-14T15:42:21", "published_display": "14 Jul 2026 15:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MBX Biosciences Appoints New CEO and CFO: Leadership Changes Announced in July 2026 8-K Filing", "summary": "MBX Biosciences, Inc. (NASDAQ: MBX) has announced significant executive leadership changes detailed in a recent Form 8-K filing. Kent P. Hawryluk will step down as CEO, with Steven Hoerter appointed as the new President and CEO, and John Smither named permanent CFO, all effective", "url": "https://www.minichart.com.sg/2026/07/14/mbx-biosciences-appoints-new-ceo-and-cfo-leadership-changes-announced-in-july-2026-8-k-filing/", "source_name": "Minichart", "published_at": "2026-07-14T01:12:19", "published_display": "14 Jul 2026 01:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MBX Biosciences stock falls on CEO and CFO leadership changes By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxOMWpycVpUaG5KTC03NFNFQWZycmhVNUdydGg5TTd6SU4zSHhDbVdoQzdGcHVmS2QyM2hQM2hrdTRmdnpoSTh6cElZemF0cFRyVFdtQnYxZ1YzZG9IN2wzZWdkaHJFX2FpbDJqa0RGWVdMNEJ2VVJWWnFRcUx0a0lZS2V6ME1sRUN4NUtoV0FEVEhZa2o5NjQ2QmttRXhROWJpeEFhODdpT2Q5ZEI1cjdaU2FMWmxPOG1aUDJoSFlIbw?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-07-13T20:37:45+00:00", "published_display": "13 Jul 2026 20:37", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MBX Biosciences names Steve Hoerter as CEO, Kent Hawryluk steps down", "summary": "MBX Biosciences has appointed Steve Hoerter as its new Chairman and CEO, succeeding co-founder Kent Hawryluk. The company also named John Smither as its permanent CFO. This leadership change comes as MBX Biosciences' stock has surged 368% over the past year, and the company is pr", "url": "https://www.investing.com/news/company-news/mbx-biosciences-names-steve-hoerter-as-ceo-kent-hawryluk-steps-down-93CH-4789240", "source_name": "Investing.com", "published_at": "2026-07-13T21:12:19", "published_display": "13 Jul 2026 21:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MBX Biosciences (Nasdaq: MBX) names new CEO and CFO, sets pay and equity", "summary": "MBX Biosciences has announced significant leadership changes, with Kent P. Hawryluk stepping down as CEO and director, effective July 13, 2026. Steven Hoerter, previously executive chairman, has been appointed as the new President and CEO, while interim CFO John Smither has been ", "url": "https://www.stocktitan.net/sec-filings/MBX/8-k-mbx-biosciences-inc-reports-material-event-fddededbbdca.html", "source_name": "Stock Titan", "published_at": "2026-07-13T21:12:19", "published_display": "13 Jul 2026 21:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MBX Biosciences stock falls on CEO and CFO leadership changes", "summary": "MBX Biosciences Inc. (NASDAQ:MBX) shares dropped 8.3% after announcements of executive leadership changes. Steve Hoerter, currently Executive Chairman, was appointed new Chairman and CEO, replacing Kent Hawryluk. John Smither, who served as Interim CFO, was made permanent Chief F", "url": "https://www.investing.com/news/stock-market-news/mbx-biosciences-stock-falls-on-ceo-and-cfo-leadership-changes-93CH-4789297", "source_name": "Investing.com", "published_at": "2026-07-13T16:34:00", "published_display": "13 Jul 2026 16:34", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPQ3B5MlVsTlBhcXdmUVllazV2SWFHTmRudHVNdFY3RUYtR1FTXzNIV1VYODF0bTMyVThkOE1LZC11TGN2dUxBZzRPTDQxUDVDdF9PWW5VUk1rZVJkdXRjbTQ2MU1wa3BtejZ5NUhWY1dQLUZLS3duak1fMzIxcnNwUmc4X3N5Q1JXMFNQY1J0ZVd5aHF4NHVUQkpnNlNUU1VWcVljNjhGbkFicUNyOXktR0lZWkVxT09oU0VQZnZObG5RMkJDWHh4czRrUktNZFNrZVhKWnF1YTZ2ZmVzTG14WG1n?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:24:17+00:00", "published_display": "13 Jul 2026 09:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of MBX Biosciences, Inc. \u2013 NASDAQ:MBX", "summary": "This article provides financial data for MBX Biosciences, Inc. (NASDAQ:MBX), specifically its enterprise value to EBIT forward. It indicates that the market was closed at the time of publication and gives an overview of the company's financial information available on TradingView", "url": "https://www.tradingview.com/symbols/NASDAQ-MBX/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-13T09:10:35", "published_display": "13 Jul 2026 09:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Candriam S.C.A. Purchases New Holdings in MBX Biosciences, Inc. $MBX", "summary": "Candriam S.C.A. has initiated a new position in MBX Biosciences, acquiring 294,374 shares valued at approximately $8.79 million during the first quarter. This move, representing 0.62% of MBX Biosciences, aligns with increased interest from other institutional investors like Welli", "url": "https://www.marketbeat.com/instant-alerts/filing-candriam-sca-purchases-new-holdings-in-mbx-biosciences-inc-mbx-2026-07-13/", "source_name": "MarketBeat", "published_at": "2026-07-13T08:10:35", "published_display": "13 Jul 2026 08:10", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of MBX Biosciences, Inc. \u2013 NASDAQ:MBX", "summary": "The article references the \"Price to sales forward\" metric for MBX Biosciences, Inc. (NASDAQ:MBX) on TradingView. It provides contextual information about accessing financial data for the company within the TradingView platform. The content is very brief, mainly serving as a navi", "url": "https://www.tradingview.com/symbols/NASDAQ-MBX/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-13T00:09:36", "published_display": "13 Jul 2026 00:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MBX Biosciences (NASDAQ:MBX) Upgraded to \"Hold\" at Wall Street Zen", "summary": "Wall Street Zen has upgraded MBX Biosciences (NASDAQ:MBX) from a \"sell\" to a \"hold\" rating. This comes amidst other analyst ratings ranging from \"Strong Buy\" to \"Sell,\" with a consensus of \"Moderate Buy\" and an average price target of $60.22. The article also notes recent stock p", "url": "https://www.marketbeat.com/instant-alerts/mbx-biosciences-nasdaqmbx-upgraded-to-hold-at-wall-street-zen-2026-07-12/", "source_name": "MarketBeat", "published_at": "2026-07-12T17:40:09", "published_display": "12 Jul 2026 17:40", "sentiment": "positive", "sentiment_pct": 65, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MBX Biosciences (NASDAQ:MBX) Trading Down 6.9% - Time to Sell?", "summary": "MBX Biosciences (NASDAQ:MBX) shares dropped 6.9% on Friday, trading at $61.17 after closing at $65.71 the previous day, with significantly lower trading volume. Analyst opinions are mixed but lean towards \"Moderate Buy\" with a consensus price target of $60.22, despite some recent", "url": "https://www.marketbeat.com/instant-alerts/mbx-biosciences-nasdaqmbx-trading-down-69-time-to-sell-2026-07-10/", "source_name": "MarketBeat", "published_at": "2026-07-10T16:41:17", "published_display": "10 Jul 2026 16:41", "sentiment": "negative", "sentiment_pct": 37, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wellington Group discloses 4.98M-share stake in MBX Biosciences (MBX)", "summary": "Wellington Management Group LLP and its affiliates have disclosed a beneficial ownership of 4,977,523 shares, or 10.46%, in MBX Biosciences common stock through a Schedule 13G/A filing. These shares are held in client accounts, with shared voting and dispositive powers across var", "url": "https://www.stocktitan.net/sec-filings/MBX/schedule-13g-a-mbx-biosciences-inc-amended-passive-investment-disclos-1bb1da05b7c9.html", "source_name": "Stock Titan", "published_at": "2026-07-08T16:59:12", "published_display": "08 Jul 2026 16:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MBX Biosciences stock hits all-time high at 59.55 USD", "summary": "MBX Biosciences Inc. (MBX) stock reached an all-time high of $59.55, trading near its 52-week high, reflecting a significant market capitalization of $2.75 billion and a 352.03% increase over the past year. This growth is attributed to investor confidence and positive company dev", "url": "https://www.investing.com/news/company-news/mbx-biosciences-stock-hits-alltime-high-at-5955-usd-93CH-4779719", "source_name": "Investing.com", "published_at": "2026-07-08T07:09:36", "published_display": "08 Jul 2026 07:09", "sentiment": "positive", "sentiment_pct": 91, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of MBX Biosciences, Inc. \u2013 NASDAQ:MBX", "summary": "This article focuses on the enterprise value to revenue forward metric for MBX Biosciences, Inc. (NASDAQ:MBX). It appears to be a financial data page from TradingView, providing an overview of various financial aspects and tools available for analyzing the company's stock.", "url": "https://www.tradingview.com/symbols/NASDAQ-MBX/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-08T01:41:32", "published_display": "08 Jul 2026 01:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MBX Biosciences stock hits all-time high at 59.55 USD By Investing.com", "summary": "MBX Biosciences Inc. (MBX) stock reached an all-time high of $59.55, trading within 1% of its 52-week high, bringing its market capitalization to $2.75 billion. This surge reflects a 352.03% increase over the past year, driven by investor confidence and positive developments, inc", "url": "https://uk.investing.com/news/stock-market-news/mbx-biosciences-stock-hits-alltime-high-at-5955-usd-93CH-4760168", "source_name": "Investing.com UK", "published_at": "2026-07-07T16:30:00", "published_display": "07 Jul 2026 16:30", "sentiment": "positive", "sentiment_pct": 93, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tenet Healthcare Stock Jumps As Analysts Hold Buy Ratings Into Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNYzlxZUxqQXJsWHRaUDE4SE1xeXUySXpBalJOamFXdlpnOHdQU25fTVFSdGZlcENQX2tLU2ljMXlvNW8xSnFNcHhsYnhJZURQSWNueTR4cVItWVdxbXFOeDNWYVRfOG9rWGpBNUUwT2lBSHVkcFdMdnhEUzdycnczUms3a3dzSDk5?oc=5", "source_name": "timothysykes.com", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Tenet Healthcare (THC) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNTGpMSWYxM2M3RmxZNHFVMm5pTnNfeTZKNzNiWHFJRTBkUDYtMWJaOFB0ZUVKYldFclQ2WFdscFJKTjdHS25XZVpMRE9CRUlSU3NDS3hKTUtaamxpREN2LTAyc3AtdWdTZlhzZ3kzYmEtMEI5QjVGZ0VVdFN2R0dKUWh2Vm9FelByMUU5N0tXQk5OeU5ZZndqekVNeEJVbHVZVTNUdmFB?oc=5", "source_name": "TradingView", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MBX Biosciences (MBX) Stock Looks Fully Valued After New Phase 2 Data", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxObTdhSlJXM3BhWXRZM1NuWVBvNFZKS09CUkMyLV93TEdVQUdycktzUG5tRnFwUFlabkluMDFsMUpYYzFiQUxPWVdwczhNeVVjN0Rvc2k3VUZuS3NlTmEycHVpMGV1eDhnaEZkQ1JCaHVkcVZnMGd6Q2xzYnVpZV9tVVRLcjZnaWd0NlRhSnRENWIxSzhBQkd5WnRxVXN4dkk?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MBX Biosciences: In Danger Of Being Outpaced By Rivals - Rating Downgrade (NASDAQ:MBX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNSURMVGN5aVQ2NXgxc3lOa0dUanhDdGM2N1d3Z1kzeVVHVndET2szbGxwZXJFQjJTZUJIWDZOcjNCYm1qUy1OdndhUnBrSzBsYjY1R1RkSXVOTFo0bVJqSHlzSUUxMVk2V2pfdlh6eW9xSm9yc2J1WGxPS3AwcG1Wb3J3QXpuaGlTNnNSY3NmOHpJY0hnT3JXYng2MnFRTDIyamdyYWdIY1BCTHYxNjdGSA?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Stock Buying Reaches US$1.06m On MBX Biosciences", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQSk5heTB4V3BZU0Nid29VdUktbHFMT3JvbDh1UzY0OGl3VTRwOUZReWlTSUpUY3dLN29aM1Y2WXI3bFo0ZFJ6WjhmU3BmZE9icjdtMEZHS081cnJxcW9qaXBmRFhKeTFneER5b3RrZmE3UWFSZ0lYX2w0YUNCVVB4QUxLNFQ3RzJCb0xuNkFzNjdWZzJGTVhwdmtFVV8?oc=5", "source_name": "Market source", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUjRRb0hlcHlOazlmelFaVVJSQWNnRmExZVBEQW1HMmVLTjNyU3d4WElsU05hdGlfYWFSY0twMTNWOVVCY0h4U2dYQ19BQl9pa3o0NWNBLW50WmFsSEVHdmJFV3JabnN5MFZpUWZabjZzY2tjMUtxbndONm9DS3NxTUp3Qjg2dWZnMDR2NXZ2eU80MWhSODVKdVgxZVJ6TWs3RFpCaDFqMXVtVkhmRVlOcWtqYUV1X1FPcGpfdERhRmwzdkZDaWxtSnJnd25Oam4yTnFHTFBkZi0tM1BZdkE?oc=5", "source_name": "StockStory", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNTTJZRVF4TFNBb3BhMW9VUnBnMVZhenZLNlZJY3Ryc3pGZ3dhZXBDY3pId0I5NFdmVTdiR2EyNXNBZFFuQ1M2M3pUTlRZdXJkbGxaT29mWm4wTG5fU2RtV1hIZWRwZUVNb3BEbTZKX3NPRV9mZVpiY3JBZDdMSDRveW1Jb0lIVmRKLVlidA?oc=5", "source_name": "Market source", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPSGpqV09Qc0RwZVU4cm1RODdrSUJFdWNYYmw5ZVNMTmhDRVhCTm15aTZSajhRckF6R194Q1hqTjZKQXJlbmJDMC1XT21TRDVfZ2xidWd4NzdxVE5oV1RURFhRMkFqajJUTnRQWm1GeUp6V1VJMzdKTzh0OGczWkp4M1VzdmR5Um43dVlSVnF2Tk1jTU9peTJvdkpHQUNjNlpSSmp0UEZwSWwzcnZZSUtJbVdiNnREOGtpaThF?oc=5", "source_name": "Stocktwits", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Puma Biotechnology's Stock Plummet Despite Beating Q4 Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUEQ4TXY0R1lWMTJIcEJySm5iaEl1UkJ6TDMxcUtQYVl3UmxYdlJnaElpdlJDLU0xTTRvT0dsellqX21Tc3lxWW9IbWxHMnFBZGlxajdnUUU2OTNVY0l3NUh0OExMUENwWGxqY1d5dXV3YmRDZm9IRzc1c3FjbUh2cGxvdEJMZ25lYXdjSUliZ0txSjVFOHJhUXNTajBLeVV0M3B4dDk4V3dfQQ?oc=5", "source_name": "Kavout | AI", "published_at": "2026-02-28T09:53:07+00:00", "published_display": "28 Feb 2026 09:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cava Stock Surges 24% After Upbeat Earnings and Strong 2026 Outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQcV9JR0t0QUpQRWhQU0JxOGZld2wxZmNTb0ZoV05TZVBhUjRxRGF2Zno5YWRaVkxKRzNsbk8yY01fdk95S09xcV9aT0FFS1A3Zzhfd0ZLVVVRVU1jY1BiZmZ6T0drMjlfLVNXMTVBZjdtWXdNTEdHTEc2ejFqX1lTREs3eXBhbWRjaUhRWHJMZlYxWGFGZnYwOUJ2Mm9uQQ?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vir Biotechnology Stock Skyrockets 65% on Positive Prostate Cancer Treatment Trial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNeEtXZ1k1WGctLWZuX0tYZE5SLWN4MU5KUktLV3NobzVheFpoMkZhdFJrWTdNelAwWGxYZUswazZtMWFUaXEzY3k0QnI0TW9IMGc2UTNzUlNmR1JxZG1JbEpQM0N3N1p4blRjaGdvMExoZzJOYWF3Tk5hajJCTlprZ3dESTVEd0Y4TXhvcElNR3Bqemd3RmNKcGxwa2dSU2phak9paE53c0t3dVFVeGZic2liZ1I0UU80TEM2WUNlOA?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSG1pQzVIRmhqTkhiWXozT29mTWM0UERfakxmOTZzdm5TZ24wZTVqLUpSWlFyWGVmYnlicGE3ZVYxOVotWU5naGM5aUZVakItUGJLTk1ZVE1mclRHd1N3N0FIWkV2TzFrT2lMNFRjcHhnVVBzTk5vNUFkLTgwNExtRWJYN1hVZzRkVjRlTktkNk1jcnpfQklCamN3NA?oc=5", "source_name": "Barron's", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molina Healthcare Stock Craters. Why Its Earnings Outlook Is So Bleak.", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPX1JJd3MzSGZ4Tl9ZWUduMTAtSUNrdVJDZFE2YnVGZzhvTUt6OXZNcHFPSG1LaWJ5a3NnQV9VeEZtYlNMVVlvaXZOanJreFVOcTd0U0phaUdhQUxjbFFwazc5S0ZYY1hWN25WalhXUGVQZEh5UnB3UDVWSzRoS3VsWnk5ek11X0k?oc=5", "source_name": "Barron's", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MBX Biosciences, Inc. Common Stock (MBX) Stock Price Today: $62.92", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVkFVX3lxTFAydHdCd3VOYnFTRkVxUDc4b0hnR2NuNTVQejdTZXo0V0JCVTZFci13SFgweVpPcXBwZUZ2RjFoZFd2a1pLOHNYeU14eHFzSF9sVHEwcXdn?oc=5", "source_name": "Gotrade", "published_at": "2026-01-13T02:49:10+00:00", "published_display": "13 Jan 2026 02:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MBX Biosciences (MBX) Stock Price, News & Analysis $MBX", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWEFVX3lxTE0ta3VHR3c1QXRsQ0hTLXJodWZ4Nll0cHRQczAtOVJTQnZKcVpCN09LVzVOY3AyTXhJUUZOY0d0N24xV1g2M2xFUG5rNFZkY3FCaXBnYVhIeHo?oc=5", "source_name": "MarketBeat", "published_at": "2025-08-24T08:04:09+00:00", "published_display": "24 Aug 2025 08:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "symbol__ Stock Quote Price and Forecast", "summary": "", "url": "https://news.google.com/rss/articles/CBMiT0FVX3lxTE9zZkRnRlpjcVVOQzd1SGZCSHYzXzR3NEdVdE95RExpdjMtbFZseEFXSVNZU21ZdERDMzk1dkV4bEctTm0xMk5TcDJKRnNnMmM?oc=5", "source_name": "CNN", "published_at": "2024-09-14T06:07:31+00:00", "published_display": "14 Sep 2024 06:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MBX Stock Price and Chart \u2014 NASDAQ:MBX", "summary": "", "url": "https://news.google.com/rss/articles/CBMiW0FVX3lxTE81VzdISUxjOUM5a1FBekZKVE5Ua3FYTGJlN3oxOElST0YtTjNFNmVpS0lzbmo1ZXV6empUNTRjOW9ONlRwbjdYaEhhT2hiUmZiSlZmVDZla3I3Q0U?oc=5", "source_name": "TradingView", "published_at": "2024-09-13T16:46:22+00:00", "published_display": "13 Sep 2024 16:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "MBX Biosciences (NASDAQ:MBX) Rating Lowered to \"Sell\" at Wall Street Zen", "summary": "Wall Street Zen has downgraded MBX Biosciences (NASDAQ:MBX) from a \"hold\" to a \"sell\" rating, despite other analysts like Barclays, Truist Financial, and Citizens JMP recently increasing their price targets. The stock currently holds a \"Moderate Buy\" consensus rating with a $63.0", "url": "https://www.marketbeat.com/instant-alerts/mbx-biosciences-nasdaqmbx-rating-lowered-to-sell-at-wall-street-zen-2026-07-20/", "source_name": "MarketBeat", "published_at": "2026-07-20T05:11:59", "published_display": "20 Jul 2026 05:11", "sentiment": "negative", "sentiment_pct": 39, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MBX Biosciences (NASDAQ:MBX) Trading 5.1% Higher - What's Next?", "summary": "MBX Biosciences (NASDAQ:MBX) shares increased by 5.1% on Friday, trading as high as $60.11 and closing at $61.30, despite a significant drop in trading volume. Analysts maintain a generally positive outlook, with a consensus \"Moderate Buy\" rating and an average price target of $6", "url": "https://www.marketbeat.com/instant-alerts/mbx-biosciences-nasdaqmbx-trading-51-higher-whats-next-2026-07-17/", "source_name": "MarketBeat", "published_at": "2026-07-17T17:11:13", "published_display": "17 Jul 2026 17:11", "sentiment": "positive", "sentiment_pct": 67, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is MBX Biosciences (MBX) Fairly Valued As New Leadership Takes Charge?", "summary": "MBX Biosciences (MBX) has appointed Steve Hoerter as CEO and Chairman and John Smither as CFO, following a significant surge in its stock price. The article examines the company's valuation using the price-to-book ratio, noting it appears expensive compared to the broader pharmac", "url": "https://www.sahmcapital.com/news/content/is-mbx-biosciences-mbx-fairly-valued-as-new-leadership-takes-charge-2026-07-17", "source_name": "Sahm", "published_at": "2026-07-17T09:11:59", "published_display": "17 Jul 2026 09:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MBX Biosciences Announces CEO Transition and Leadership Updates", "summary": "MBX Biosciences announced a leadership transition, with CEO Kent P. Hawryluk stepping down on July 13, 2026. Steven Hoerter has been named the new President, CEO, and principal executive officer, while John Smither is confirmed as CFO. The company's stock currently holds a \"Buy\" ", "url": "https://www.theglobeandmail.com/investing/markets/stocks/MBX/pressreleases/3284381/mbx-biosciences-announces-ceo-transition-and-leadership-updates/", "source_name": "The Globe and Mail", "published_at": "2026-07-15T09:09:43", "published_display": "15 Jul 2026 09:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "$MBX stock is down 9% today. Here's what we see in our data.", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOemc1WEs1T3MxeGlNclJLMnU5SXlzQlJmcmxheGQzQW54RlJBc1c5dnprOUU4cHRHLW1Fa2Z1VjQzejNkNjRlelpqZWxLMm5qZVVpMFVNdjJ0TmdFM296WWJJQXdESVRwZmIzRmU2VElQRXBDZGcwODVBbTdZaUZPV2tXV0F0M0xRWlVfSm5mWXF4X1NHR3lmOGotSXE5cmpJ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-14T14:52:00+00:00", "published_display": "14 Jul 2026 14:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MBX Biosciences (NASDAQ:MBX) Shares Gap Down - Should You Sell?", "summary": "MBX Biosciences (NASDAQ:MBX) experienced a gap down at market open, falling from $60.04 to $52.82 before trading at $55.83. Despite the dip, analysts generally maintain a \"Moderate Buy\" consensus with an average price target of $60.22, though one analyst still recommends selling.", "url": "https://www.marketbeat.com/instant-alerts/mbx-biosciences-nasdaqmbx-shares-gap-down-should-you-sell-2026-07-14/", "source_name": "MarketBeat", "published_at": "2026-07-14T15:42:21", "published_display": "14 Jul 2026 15:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MBX Biosciences Appoints New CEO and CFO: Leadership Changes Announced in July 2026 8-K Filing", "summary": "MBX Biosciences, Inc. (NASDAQ: MBX) has announced significant executive leadership changes detailed in a recent Form 8-K filing. Kent P. Hawryluk will step down as CEO, with Steven Hoerter appointed as the new President and CEO, and John Smither named permanent CFO, all effective", "url": "https://www.minichart.com.sg/2026/07/14/mbx-biosciences-appoints-new-ceo-and-cfo-leadership-changes-announced-in-july-2026-8-k-filing/", "source_name": "Minichart", "published_at": "2026-07-14T01:12:19", "published_display": "14 Jul 2026 01:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MBX Biosciences stock falls on CEO and CFO leadership changes By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxOMWpycVpUaG5KTC03NFNFQWZycmhVNUdydGg5TTd6SU4zSHhDbVdoQzdGcHVmS2QyM2hQM2hrdTRmdnpoSTh6cElZemF0cFRyVFdtQnYxZ1YzZG9IN2wzZWdkaHJFX2FpbDJqa0RGWVdMNEJ2VVJWWnFRcUx0a0lZS2V6ME1sRUN4NUtoV0FEVEhZa2o5NjQ2QmttRXhROWJpeEFhODdpT2Q5ZEI1cjdaU2FMWmxPOG1aUDJoSFlIbw?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-07-13T20:37:45+00:00", "published_display": "13 Jul 2026 20:37", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MBX Biosciences names Steve Hoerter as CEO, Kent Hawryluk steps down", "summary": "MBX Biosciences has appointed Steve Hoerter as its new Chairman and CEO, succeeding co-founder Kent Hawryluk. The company also named John Smither as its permanent CFO. This leadership change comes as MBX Biosciences' stock has surged 368% over the past year, and the company is pr", "url": "https://www.investing.com/news/company-news/mbx-biosciences-names-steve-hoerter-as-ceo-kent-hawryluk-steps-down-93CH-4789240", "source_name": "Investing.com", "published_at": "2026-07-13T21:12:19", "published_display": "13 Jul 2026 21:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MBX Biosciences (Nasdaq: MBX) names new CEO and CFO, sets pay and equity", "summary": "MBX Biosciences has announced significant leadership changes, with Kent P. Hawryluk stepping down as CEO and director, effective July 13, 2026. Steven Hoerter, previously executive chairman, has been appointed as the new President and CEO, while interim CFO John Smither has been ", "url": "https://www.stocktitan.net/sec-filings/MBX/8-k-mbx-biosciences-inc-reports-material-event-fddededbbdca.html", "source_name": "Stock Titan", "published_at": "2026-07-13T21:12:19", "published_display": "13 Jul 2026 21:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MBX Biosciences stock falls on CEO and CFO leadership changes", "summary": "MBX Biosciences Inc. (NASDAQ:MBX) shares dropped 8.3% after announcements of executive leadership changes. Steve Hoerter, currently Executive Chairman, was appointed new Chairman and CEO, replacing Kent Hawryluk. John Smither, who served as Interim CFO, was made permanent Chief F", "url": "https://www.investing.com/news/stock-market-news/mbx-biosciences-stock-falls-on-ceo-and-cfo-leadership-changes-93CH-4789297", "source_name": "Investing.com", "published_at": "2026-07-13T16:34:00", "published_display": "13 Jul 2026 16:34", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPQ3B5MlVsTlBhcXdmUVllazV2SWFHTmRudHVNdFY3RUYtR1FTXzNIV1VYODF0bTMyVThkOE1LZC11TGN2dUxBZzRPTDQxUDVDdF9PWW5VUk1rZVJkdXRjbTQ2MU1wa3BtejZ5NUhWY1dQLUZLS3duak1fMzIxcnNwUmc4X3N5Q1JXMFNQY1J0ZVd5aHF4NHVUQkpnNlNUU1VWcVljNjhGbkFicUNyOXktR0lZWkVxT09oU0VQZnZObG5RMkJDWHh4czRrUktNZFNrZVhKWnF1YTZ2ZmVzTG14WG1n?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:24:17+00:00", "published_display": "13 Jul 2026 09:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of MBX Biosciences, Inc. \u2013 NASDAQ:MBX", "summary": "This article provides financial data for MBX Biosciences, Inc. (NASDAQ:MBX), specifically its enterprise value to EBIT forward. It indicates that the market was closed at the time of publication and gives an overview of the company's financial information available on TradingView", "url": "https://www.tradingview.com/symbols/NASDAQ-MBX/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-13T09:10:35", "published_display": "13 Jul 2026 09:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Candriam S.C.A. Purchases New Holdings in MBX Biosciences, Inc. $MBX", "summary": "Candriam S.C.A. has initiated a new position in MBX Biosciences, acquiring 294,374 shares valued at approximately $8.79 million during the first quarter. This move, representing 0.62% of MBX Biosciences, aligns with increased interest from other institutional investors like Welli", "url": "https://www.marketbeat.com/instant-alerts/filing-candriam-sca-purchases-new-holdings-in-mbx-biosciences-inc-mbx-2026-07-13/", "source_name": "MarketBeat", "published_at": "2026-07-13T08:10:35", "published_display": "13 Jul 2026 08:10", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of MBX Biosciences, Inc. \u2013 NASDAQ:MBX", "summary": "The article references the \"Price to sales forward\" metric for MBX Biosciences, Inc. (NASDAQ:MBX) on TradingView. It provides contextual information about accessing financial data for the company within the TradingView platform. The content is very brief, mainly serving as a navi", "url": "https://www.tradingview.com/symbols/NASDAQ-MBX/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-13T00:09:36", "published_display": "13 Jul 2026 00:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MBX Biosciences (NASDAQ:MBX) Upgraded to \"Hold\" at Wall Street Zen", "summary": "Wall Street Zen has upgraded MBX Biosciences (NASDAQ:MBX) from a \"sell\" to a \"hold\" rating. This comes amidst other analyst ratings ranging from \"Strong Buy\" to \"Sell,\" with a consensus of \"Moderate Buy\" and an average price target of $60.22. The article also notes recent stock p", "url": "https://www.marketbeat.com/instant-alerts/mbx-biosciences-nasdaqmbx-upgraded-to-hold-at-wall-street-zen-2026-07-12/", "source_name": "MarketBeat", "published_at": "2026-07-12T17:40:09", "published_display": "12 Jul 2026 17:40", "sentiment": "positive", "sentiment_pct": 65, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MBX Biosciences (NASDAQ:MBX) Trading Down 6.9% - Time to Sell?", "summary": "MBX Biosciences (NASDAQ:MBX) shares dropped 6.9% on Friday, trading at $61.17 after closing at $65.71 the previous day, with significantly lower trading volume. Analyst opinions are mixed but lean towards \"Moderate Buy\" with a consensus price target of $60.22, despite some recent", "url": "https://www.marketbeat.com/instant-alerts/mbx-biosciences-nasdaqmbx-trading-down-69-time-to-sell-2026-07-10/", "source_name": "MarketBeat", "published_at": "2026-07-10T16:41:17", "published_display": "10 Jul 2026 16:41", "sentiment": "negative", "sentiment_pct": 37, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wellington Group discloses 4.98M-share stake in MBX Biosciences (MBX)", "summary": "Wellington Management Group LLP and its affiliates have disclosed a beneficial ownership of 4,977,523 shares, or 10.46%, in MBX Biosciences common stock through a Schedule 13G/A filing. These shares are held in client accounts, with shared voting and dispositive powers across var", "url": "https://www.stocktitan.net/sec-filings/MBX/schedule-13g-a-mbx-biosciences-inc-amended-passive-investment-disclos-1bb1da05b7c9.html", "source_name": "Stock Titan", "published_at": "2026-07-08T16:59:12", "published_display": "08 Jul 2026 16:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MBX Biosciences stock hits all-time high at 59.55 USD", "summary": "MBX Biosciences Inc. (MBX) stock reached an all-time high of $59.55, trading near its 52-week high, reflecting a significant market capitalization of $2.75 billion and a 352.03% increase over the past year. This growth is attributed to investor confidence and positive company dev", "url": "https://www.investing.com/news/company-news/mbx-biosciences-stock-hits-alltime-high-at-5955-usd-93CH-4779719", "source_name": "Investing.com", "published_at": "2026-07-08T07:09:36", "published_display": "08 Jul 2026 07:09", "sentiment": "positive", "sentiment_pct": 91, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of MBX Biosciences, Inc. \u2013 NASDAQ:MBX", "summary": "This article focuses on the enterprise value to revenue forward metric for MBX Biosciences, Inc. (NASDAQ:MBX). It appears to be a financial data page from TradingView, providing an overview of various financial aspects and tools available for analyzing the company's stock.", "url": "https://www.tradingview.com/symbols/NASDAQ-MBX/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-08T01:41:32", "published_display": "08 Jul 2026 01:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MBX Biosciences stock hits all-time high at 59.55 USD By Investing.com", "summary": "MBX Biosciences Inc. (MBX) stock reached an all-time high of $59.55, trading within 1% of its 52-week high, bringing its market capitalization to $2.75 billion. This surge reflects a 352.03% increase over the past year, driven by investor confidence and positive developments, inc", "url": "https://uk.investing.com/news/stock-market-news/mbx-biosciences-stock-hits-alltime-high-at-5955-usd-93CH-4760168", "source_name": "Investing.com UK", "published_at": "2026-07-07T16:30:00", "published_display": "07 Jul 2026 16:30", "sentiment": "positive", "sentiment_pct": 93, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tenet Healthcare Stock Jumps As Analysts Hold Buy Ratings Into Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNYzlxZUxqQXJsWHRaUDE4SE1xeXUySXpBalJOamFXdlpnOHdQU25fTVFSdGZlcENQX2tLU2ljMXlvNW8xSnFNcHhsYnhJZURQSWNueTR4cVItWVdxbXFOeDNWYVRfOG9rWGpBNUUwT2lBSHVkcFdMdnhEUzdycnczUms3a3dzSDk5?oc=5", "source_name": "timothysykes.com", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Tenet Healthcare (THC) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNTGpMSWYxM2M3RmxZNHFVMm5pTnNfeTZKNzNiWHFJRTBkUDYtMWJaOFB0ZUVKYldFclQ2WFdscFJKTjdHS25XZVpMRE9CRUlSU3NDS3hKTUtaamxpREN2LTAyc3AtdWdTZlhzZ3kzYmEtMEI5QjVGZ0VVdFN2R0dKUWh2Vm9FelByMUU5N0tXQk5OeU5ZZndqekVNeEJVbHVZVTNUdmFB?oc=5", "source_name": "TradingView", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MBX Biosciences (MBX) Stock Looks Fully Valued After New Phase 2 Data", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxObTdhSlJXM3BhWXRZM1NuWVBvNFZKS09CUkMyLV93TEdVQUdycktzUG5tRnFwUFlabkluMDFsMUpYYzFiQUxPWVdwczhNeVVjN0Rvc2k3VUZuS3NlTmEycHVpMGV1eDhnaEZkQ1JCaHVkcVZnMGd6Q2xzYnVpZV9tVVRLcjZnaWd0NlRhSnRENWIxSzhBQkd5WnRxVXN4dkk?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MBX Biosciences: In Danger Of Being Outpaced By Rivals - Rating Downgrade (NASDAQ:MBX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNSURMVGN5aVQ2NXgxc3lOa0dUanhDdGM2N1d3Z1kzeVVHVndET2szbGxwZXJFQjJTZUJIWDZOcjNCYm1qUy1OdndhUnBrSzBsYjY1R1RkSXVOTFo0bVJqSHlzSUUxMVk2V2pfdlh6eW9xSm9yc2J1WGxPS3AwcG1Wb3J3QXpuaGlTNnNSY3NmOHpJY0hnT3JXYng2MnFRTDIyamdyYWdIY1BCTHYxNjdGSA?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Stock Buying Reaches US$1.06m On MBX Biosciences", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQSk5heTB4V3BZU0Nid29VdUktbHFMT3JvbDh1UzY0OGl3VTRwOUZReWlTSUpUY3dLN29aM1Y2WXI3bFo0ZFJ6WjhmU3BmZE9icjdtMEZHS081cnJxcW9qaXBmRFhKeTFneER5b3RrZmE3UWFSZ0lYX2w0YUNCVVB4QUxLNFQ3RzJCb0xuNkFzNjdWZzJGTVhwdmtFVV8?oc=5", "source_name": "Market source", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUjRRb0hlcHlOazlmelFaVVJSQWNnRmExZVBEQW1HMmVLTjNyU3d4WElsU05hdGlfYWFSY0twMTNWOVVCY0h4U2dYQ19BQl9pa3o0NWNBLW50WmFsSEVHdmJFV3JabnN5MFZpUWZabjZzY2tjMUtxbndONm9DS3NxTUp3Qjg2dWZnMDR2NXZ2eU80MWhSODVKdVgxZVJ6TWs3RFpCaDFqMXVtVkhmRVlOcWtqYUV1X1FPcGpfdERhRmwzdkZDaWxtSnJnd25Oam4yTnFHTFBkZi0tM1BZdkE?oc=5", "source_name": "StockStory", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNTTJZRVF4TFNBb3BhMW9VUnBnMVZhenZLNlZJY3Ryc3pGZ3dhZXBDY3pId0I5NFdmVTdiR2EyNXNBZFFuQ1M2M3pUTlRZdXJkbGxaT29mWm4wTG5fU2RtV1hIZWRwZUVNb3BEbTZKX3NPRV9mZVpiY3JBZDdMSDRveW1Jb0lIVmRKLVlidA?oc=5", "source_name": "Market source", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPSGpqV09Qc0RwZVU4cm1RODdrSUJFdWNYYmw5ZVNMTmhDRVhCTm15aTZSajhRckF6R194Q1hqTjZKQXJlbmJDMC1XT21TRDVfZ2xidWd4NzdxVE5oV1RURFhRMkFqajJUTnRQWm1GeUp6V1VJMzdKTzh0OGczWkp4M1VzdmR5Um43dVlSVnF2Tk1jTU9peTJvdkpHQUNjNlpSSmp0UEZwSWwzcnZZSUtJbVdiNnREOGtpaThF?oc=5", "source_name": "Stocktwits", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Puma Biotechnology's Stock Plummet Despite Beating Q4 Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUEQ4TXY0R1lWMTJIcEJySm5iaEl1UkJ6TDMxcUtQYVl3UmxYdlJnaElpdlJDLU0xTTRvT0dsellqX21Tc3lxWW9IbWxHMnFBZGlxajdnUUU2OTNVY0l3NUh0OExMUENwWGxqY1d5dXV3YmRDZm9IRzc1c3FjbUh2cGxvdEJMZ25lYXdjSUliZ0txSjVFOHJhUXNTajBLeVV0M3B4dDk4V3dfQQ?oc=5", "source_name": "Kavout | AI", "published_at": "2026-02-28T09:53:07+00:00", "published_display": "28 Feb 2026 09:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cava Stock Surges 24% After Upbeat Earnings and Strong 2026 Outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQcV9JR0t0QUpQRWhQU0JxOGZld2wxZmNTb0ZoV05TZVBhUjRxRGF2Zno5YWRaVkxKRzNsbk8yY01fdk95S09xcV9aT0FFS1A3Zzhfd0ZLVVVRVU1jY1BiZmZ6T0drMjlfLVNXMTVBZjdtWXdNTEdHTEc2ejFqX1lTREs3eXBhbWRjaUhRWHJMZlYxWGFGZnYwOUJ2Mm9uQQ?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vir Biotechnology Stock Skyrockets 65% on Positive Prostate Cancer Treatment Trial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNeEtXZ1k1WGctLWZuX0tYZE5SLWN4MU5KUktLV3NobzVheFpoMkZhdFJrWTdNelAwWGxYZUswazZtMWFUaXEzY3k0QnI0TW9IMGc2UTNzUlNmR1JxZG1JbEpQM0N3N1p4blRjaGdvMExoZzJOYWF3Tk5hajJCTlprZ3dESTVEd0Y4TXhvcElNR3Bqemd3RmNKcGxwa2dSU2phak9paE53c0t3dVFVeGZic2liZ1I0UU80TEM2WUNlOA?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSG1pQzVIRmhqTkhiWXozT29mTWM0UERfakxmOTZzdm5TZ24wZTVqLUpSWlFyWGVmYnlicGE3ZVYxOVotWU5naGM5aUZVakItUGJLTk1ZVE1mclRHd1N3N0FIWkV2TzFrT2lMNFRjcHhnVVBzTk5vNUFkLTgwNExtRWJYN1hVZzRkVjRlTktkNk1jcnpfQklCamN3NA?oc=5", "source_name": "Barron's", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molina Healthcare Stock Craters. Why Its Earnings Outlook Is So Bleak.", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPX1JJd3MzSGZ4Tl9ZWUduMTAtSUNrdVJDZFE2YnVGZzhvTUt6OXZNcHFPSG1LaWJ5a3NnQV9VeEZtYlNMVVlvaXZOanJreFVOcTd0U0phaUdhQUxjbFFwazc5S0ZYY1hWN25WalhXUGVQZEh5UnB3UDVWSzRoS3VsWnk5ek11X0k?oc=5", "source_name": "Barron's", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MBX Biosciences, Inc. Common Stock (MBX) Stock Price Today: $62.92", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVkFVX3lxTFAydHdCd3VOYnFTRkVxUDc4b0hnR2NuNTVQejdTZXo0V0JCVTZFci13SFgweVpPcXBwZUZ2RjFoZFd2a1pLOHNYeU14eHFzSF9sVHEwcXdn?oc=5", "source_name": "Gotrade", "published_at": "2026-01-13T02:49:10+00:00", "published_display": "13 Jan 2026 02:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MBX Biosciences (MBX) Stock Price, News & Analysis $MBX", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWEFVX3lxTE0ta3VHR3c1QXRsQ0hTLXJodWZ4Nll0cHRQczAtOVJTQnZKcVpCN09LVzVOY3AyTXhJUUZOY0d0N24xV1g2M2xFUG5rNFZkY3FCaXBnYVhIeHo?oc=5", "source_name": "MarketBeat", "published_at": "2025-08-24T08:04:09+00:00", "published_display": "24 Aug 2025 08:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "symbol__ Stock Quote Price and Forecast", "summary": "", "url": "https://news.google.com/rss/articles/CBMiT0FVX3lxTE9zZkRnRlpjcVVOQzd1SGZCSHYzXzR3NEdVdE95RExpdjMtbFZseEFXSVNZU21ZdERDMzk1dkV4bEctTm0xMk5TcDJKRnNnMmM?oc=5", "source_name": "CNN", "published_at": "2024-09-14T06:07:31+00:00", "published_display": "14 Sep 2024 06:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MBX Stock Price and Chart \u2014 NASDAQ:MBX", "summary": "", "url": "https://news.google.com/rss/articles/CBMiW0FVX3lxTE81VzdISUxjOUM5a1FBekZKVE5Ua3FYTGJlN3oxOElST0YtTjNFNmVpS0lzbmo1ZXV6empUNTRjOW9ONlRwbjdYaEhhT2hiUmZiSlZmVDZla3I3Q0U?oc=5", "source_name": "TradingView", "published_at": "2024-09-13T16:46:22+00:00", "published_display": "13 Sep 2024 16:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxQcjZqdzdBcURDdWxCZUtoU1dTaHYtVUFRdlo1a3ZGZGY3a1dBX2x2UVE3Y1hoX1duLXhGU2p0UXU2eTctNng5eFJ5c1M0bHBNQ0VmZTFZanhYU21yTVo0UTQtVENveVV1aWdpc3luUlgza3AyUEI2OGx4aEhXc0pBTHpWUThSYXI1S3RTS21lQ21vWjd6MGY4ZDRwVWlEakc3SmFKN09aM0Rlb2pFT3BNNW1GTExnSElFb2NqR3JhX0J3MlptQy1mMk9IOTZtdS1HU25fLU9aOU9XZi1PRDlkZVI2cnhackHSAewBQVVfeXFMTlc2N3pIUkxDd1NtTlVRMEdac1JNSDF3cUNidkZrTElQREZaUTZjZmFHdUVWYW8wcDg1LThGbnlPb0VQUFI4ZXdjSXR6Ym5DREM1X2lyQUtYTzF3XzBBTGRGcEZQQ3FjLWxCQ0locVM2dGZJR1kxYmlBQXdsbFhfbFFISS1wSUkxQmp4U2d2Z3JHbXRPMUpnajBydTRmNnQzZmF5eEdzOVFRNUdDNVV0aDJQNERCaXN3ZGo1UUc1ZGkwOFYzcDgxS1ltZllDeTFxNFIxT3FyOUxLMFNrLUhtOFNFV0xMYkM5TlpWMzk?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 90, "total_relevant": 49, "sentiment_summary": {"positive": 12, "negative": 7, "neutral": 30, "score": 53, "total": 49, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 13.55, "count": 24}, {"event": "earnings", "label": "Earnings", "weight": 8.6, "count": 17}, {"event": "analyst", "label": "Analyst action", "weight": 3.65, "count": 6}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 12, "negative_events": 7}, "market_context": {"has_market_context": true, "latest_close": 62.92, "latest_week": "2026-07-17", "one_week_move": 3.1, "four_week_move": 46.2, "twelve_week_move": 96.9, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.613106, "market_dynamics_buy_signal": false, "relative_strength": 96.205028, "fair_value_gap": 179.4, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 45.2893, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+3.1% over one week, +46.2% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 61, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 9}, {"label": "MarketBeat", "count": 7}, {"label": "TradingView", "count": 6}, {"label": "Investing.com", "count": 3}, {"label": "simplywall.st", "count": 3}, {"label": "Stock Titan", "count": 2}, {"label": "TIKR.com", "count": 2}, {"label": "Barron's", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 41}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 24}, {"label": "Earnings", "count": 17}, {"label": "Analyst action", "count": 6}, {"label": "Deals and strategy", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "41", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "3", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+3.1% over one week, +46.2% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "MBX Biosciences (NASDAQ:MBX) Rating Lowered to \"Sell\" at Wall Street Zen"}], "updated_at": "2026-07-21T00:51:45.001076+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}